DRUG
UBS Group’s Bright Minds Biosciences DRUG Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $50K | Sell |
1,914
-9,621
| -83% | -$251K | ﹤0.01% | 6488 |
|
|
2025
Q1 | $416K | Buy |
11,535
+1,374
| +14% | +$49.6K | ﹤0.01% | 4800 |
|
|
2024
Q4 | $366K | Buy |
10,161
+6,754
| +198% | +$243K | ﹤0.01% | 4895 |
|
|
2024
Q3 | $3.99K | Buy |
+3,407
| New | +$3.99K | ﹤0.01% | 6985 |
|
|
2024
Q1 | – | Sell |
-622
| Closed | -$889 | – | 8208 |
|
|
2023
Q4 | $889 | Buy |
+622
| New | +$889 | ﹤0.01% | 7267 |
|
|
2023
Q3 | – | Sell |
-2,098
| Closed | -$1.2K | – | 8369 |
|
|
2023
Q2 | $1.2K | Sell |
2,098
-8,803
| -81% | -$5.02K | ﹤0.01% | 6903 |
|
|
2023
Q1 | $4.8K | Buy |
10,901
+5,691
| +109% | +$2.5K | ﹤0.01% | 7044 |
|
|
2022
Q4 | $3.86K | Sell |
5,210
-9,624
| -65% | -$7.12K | ﹤0.01% | 8242 |
|
|
2022
Q3 | $18K | Buy |
14,834
+7,557
| +104% | +$9.17K | ﹤0.01% | 6421 |
|
|
2022
Q2 | $6K | Buy |
7,277
+3,826
| +111% | +$3.16K | ﹤0.01% | 7623 |
|
|
2022
Q1 | $5K | Buy |
3,451
+1,893
| +122% | +$2.74K | ﹤0.01% | 8052 |
|
|
2021
Q4 | $5K | Buy |
+1,558
| New | +$5K | ﹤0.01% | 8262 |
|